Report Categories
View AllRecent Articles
View All
Relay Therapeutics RLAY Drops 196 Key Support at 1190 20260515
Iran War Inflation Accelerates Japans Economic Strain Faster Than Past Oil Crises
Luxury Hotel Chains Express Confidence in Sri Lankas Tourism Recovery
Bond Market Signals Concerns Over Feds Inflation Response Under Warshs Leadership
BrightSpring BTSGU Q1 2026 Earnings EPS 039 Beats Estimates
Zydus Lifesciences Surges to Record High After Strong Quarterly Earnings and Share Buyback Announcement
Japans Nikkei Surges on AI Optimism and Geopolitical Easing
Chimera 2030 CIMP Q1 2026 Earnings EPS 054 Beats Estimates
Morocco Eyes Tourism Growth in Western Sahara Amid Sovereignty Dispute
Kevin Warshs Potential Fed Regime Change Could Reshape Wall Streets Market Plumbing
Nexpace Launches NXPC Buyback Program to Strengthen UserDriven Growth in MapleStory Universe
US Stock Futures Bond Yields Decline After Reports Putin Updated Nuclear Doctrine
Chinas APEC Trade Call Underscores Diplomatic Signals as Commerce Minister Skips Opening
AAR Corp AIR Q1 2026 Earnings EPS Surges Past Estimates as Aftersales Momentum Continues
ISSC Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher
WEC Q1 2026 Earnings EPS Surpasses Expectations Stock Rises
BBDC Q1 2026 Earnings EPS Falls Short as Stock Rises
Heidmar Maritime Holdings Corp HMR Q4 2025 Earnings EPS Misses Estimates Sharply Yet Stock Surges Over 29
Autolus Therapeutics AUTL Edges Higher Testing Resistance Near 181
Afya Limited AFYA Faces Modest Decline Amid Consolidation Near Key Levels
Mesa Royalty Trust MTR Stages a 455 Rebound Key Levels in Focus
Stanley Black Decker SWK Posts Modest Gain Consolidating Near Support
Tesla Brings Full SelfDriving Supervised to China Amid Intensifying EV Competition
Silver Price Outlook How Industrial Demand and Market Trends May Shape the Next Decade
Zscaler Shares Plunge on Disappointing Revenue Outlook
Prediction Markets Spark Legal Clash Between State Regulators and Federal Authorities
ANRO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline
SPGI Q1 2026 Earnings Earnings Beat Estimates Despite Modest Stock Reaction
MIST Q1 2026 Earnings Significant Earnings Miss and Stock Decline Highlight Pipeline Uncertainty
VST Q1 2026 Earnings Massive EPS Surprise Drives Stock Rally
CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue
BDSX Q1 2026 Earnings EPS Surprises to the Upside Amid Operational Progress